TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SVRA

Savara Inc

Healthcare · Biotechnology

5.40$ -0.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement SVRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0%
0.0% 270,370.4% 2,045.5% 13,633.5% 2,899,100.0%
100.0% -270,270.4% 100.0% -13,533.5% -2,899,100.0%
1,255,491.0% 52,340,740.7% 2,045.5% 13,633.5% 2,899,100.0%
612,919.9% 20,301,851.9% 705.0% 4,655.3% 1,235,000.0%
1,873,901.8% 72,912,963.0% 2,837.0% 5,649.4% 1,248,600.0%
-1,891,408.3% -72,912,963.0% -2,737.0% -19,182.9% -4,147,700.0%
0.0% 1,116,666.7% 117.0% 576.7% 228,200.0%
-1,854,134.4% -73,781,481.5% -2,820.0% -19,305.4% -4,301,400.0%
-19,767.4% 875,925.9% -89.3% 576.7% 228,200.0%
-1,854,134.4% -73,781,481.5% -2,730.8% -19,305.4% -4,301,400.0%
-1,848,643.4% -72,394,444.4% -2,620.5% -17,841.2% -4,049,700.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?